You are here

Article Text

Article menu
Download PDFPDF
Treatment
Supplemental perioperative oxygen at 80% FIO2 reduced surgical site infections in elective colorectal surgery

https://doi.org/10.1136/ebn.9.2.52

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Belda FJ, Aguilera L, García de la Asunción J, et al. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA 2005;294:2035–42.OpenUrlCrossRefPubMedWeb of Science

    Q In patients having elective colorectal resection, does supplemental perioperative oxygen reduce the risk of surgical site infection (SSI)?

    METHODS

    Embedded ImageDesign:

    randomised controlled trial (RCT).

    Embedded ImageAllocation:

    concealed.

    Embedded ImageBlinding:

    blinded (patients, surgical team, data collectors, outcome assessors, and monitoring committee).

    Embedded ImageFollow up period:

    14 days after surgery.

    Embedded ImageSetting:

    14 hospitals in Spain.

    Embedded ImagePatients:

    300 patients 18–80 years of age who were having elective colorectal resection. Exclusion criteria were minor colon surgery (eg, polypectomy or isolated colostomy) or laparoscopic surgery, expected duration of surgery <1 hour, fever or existing signs of infection, diabetes mellitus, HIV infection, >20% weight loss in past 3 months, serum albumin concentration <30 g/l, or leucocyte count <2500 cells/ml.

    Embedded ImageIntervention:

    during surgery, patients were administered an …

    View Full Text

    Footnotes

    • For correspondence: Dr F J Belda, Department of Anesthesiology and Critical Care, Hospital Clínico Universitario de Valencia, Valencia, Spain. fjbelda{at}uv.es

    • Sources of funding: in part, Air-Liquide Medicinal, Spain and Air-Liquide Santé, France.